QA: Arbutus Biopharma Corp in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001447028_2024_Arbutus_Biopharma_Corp.pdf

Logs

Graph

Absolute values for 0001447028, Arbutus Biopharma Corp

  xvar xval
0 AssetsCurrent 132,027,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,674,000
3 remainder_Assets 7,700,000
4 LiabilitiesCurrent 22,487,000
5 LiabilitiesNoncurrent 1,343,000
6 remainder_Liabilities 14,553,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,509,452
9 ResearchAndDevelopmentExpense 64,913,247
10 remainder_Expenses 2,100,800
11 remainder_Revenues 25,623,671
12 remainder_NetIncome 4,203,415
13 remainder_ComprehensiveNetIncome 819,335
  yvar yval
0 Assets 144,401,000
1 Liabilities 38,383,000
2 Expenses 89,523,499
3 Revenues 25,623,671
4 StockholdersEquity 106,018,000
5 NetIncome -59,696,413
6 ComprehensiveNetIncome -59,286,746
7 BaseVar 151,476,960
8 EconomicCapitalRatiobeforeLimitedLiability 1.88
9 EconomicCapitalRatio 2.94

Edgar->Model Mapping

Feature Distribution

Change over Time